For More Information

If you or someone you know may be eligible to participate in the FALCON trial, he or she can contact Oxigene Inc. at 877-638-0070.

You can also email the FALCON clinical trial support team at falcon@oxigene.com.

Please check the clinical trial site list to see if there is a site near you.

FALCON Trial Sponsor

About OXiGENE, Inc.

OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The Company's major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients. For more information on OXiGENE, please visit the company's website at www.oxigene.com.